136 related articles for article (PubMed ID: 34401057)
1. pH-driven entrapment of enrofloxacin in casein-based nanoparticles for the enhancement of oral bioavailability.
Yuan ZX; Deng S; Chen L; Hu Y; Gu J; He L
Food Sci Nutr; 2021 Aug; 9(8):4057-4067. PubMed ID: 34401057
[TBL] [Abstract][Full Text] [Related]
2. Casein nanoparticles as oral delivery carriers of mequindox for the improved bioavailability.
Chen L; Wei J; An M; Zhang L; Lin S; Shu G; Yuan Z; Lin J; Peng G; Liang X; Yin L; Zhang W; Zhao L; Fu H
Colloids Surf B Biointerfaces; 2020 Nov; 195():111221. PubMed ID: 32652401
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.
Li C; Zhou K; Chen D; Xu W; Tao Y; Pan Y; Meng K; Shabbir MAB; Liu Q; Huang L; Xie S
Int J Nanomedicine; 2019; 14():1619-1631. PubMed ID: 30880969
[TBL] [Abstract][Full Text] [Related]
4. Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles.
Xu W; Deng Z; Xiang Y; Zhu D; Yi D; Mo Y; Liu Y; Qin L; Huang L; Wan B; Wu L; Feng X; He J
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145677
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and
Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
[TBL] [Abstract][Full Text] [Related]
6. Formulation and
Madan JR; Ansari IN; Dua K; Awasthi R
Adv Pharm Bull; 2020 Jul; 10(3):408-417. PubMed ID: 32665899
[No Abstract] [Full Text] [Related]
7. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
8. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
[TBL] [Abstract][Full Text] [Related]
9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
10. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
Gera S; Talluri S; Rangaraj N; Sampathi S
AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and sustained release property of Fe
Li Y; Bi HY; Li H; Mao XM; Liang YQ
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():886-891. PubMed ID: 28576064
[TBL] [Abstract][Full Text] [Related]
12. Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments.
Maghrabia A; Boughdady M; Meshali M
Int J Nanomedicine; 2021; 16():5937-5953. PubMed ID: 34511899
[TBL] [Abstract][Full Text] [Related]
13. Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3
Alhamhoom Y; Honmane SM; Hani U; Osmani RAM; Kandasamy G; Vasudevan R; Paramshetti S; R Dudhal R; K Kengar N; Charde MS
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771784
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
15. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of enrofloxacin and danofloxacin in premature calves.
Corum O; Altan F; Yildiz R; Ider M; Ok M; Uney K
J Vet Pharmacol Ther; 2019 Nov; 42(6):624-631. PubMed ID: 31190327
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability.
Rangaraj N; Pailla SR; Chowta P; Sampathi S
AAPS PharmSciTech; 2019 Oct; 20(8):326. PubMed ID: 31659558
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
Dudhipala N; Ay AA
Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP
Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399
[TBL] [Abstract][Full Text] [Related]
20. Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.
Gardouh AR; Srag El-Din ASG; Salem MSH; Moustafa Y; Gad S
Drug Des Devel Ther; 2021; 15():3071-3093. PubMed ID: 34305395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
